<DOC>
	<DOCNO>NCT02033707</DOCNO>
	<brief_summary>This non-treatment study investigate effect mood performance cause hallucinogen psychoactive compound .</brief_summary>
	<brief_title>Effects Hallucinogens Other Drugs Mood Performance</brief_title>
	<detailed_description>Twenty volunteer 21-50 year old participate 16 total session , include session : screening , preparation , experiment/drug , immediate follow-up , 1-month follow-up 1 post completion urine collection . On five experimental session participant orally ingest capsule either placebo varying dose one 18 different psychoactive compound . Subjective drug effect examine method previously use laboratory characterize effect psychoactive substance variety different class . Volunteers swallow capsule contain various dos drug , complete task session , rate effect drug complete questionnaire end session describe .</detailed_description>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Scopolamine Hydrobromide</mesh_term>
	<mesh_term>Butylscopolammonium Bromide</mesh_term>
	<mesh_term>Hypnotics Sedatives</mesh_term>
	<mesh_term>Hallucinogens</mesh_term>
	<mesh_term>Anti-Anxiety Agents</mesh_term>
	<mesh_term>Histamine Antagonists</mesh_term>
	<mesh_term>Histamine H1 Antagonists</mesh_term>
	<criteria>Be 21 50 year old Have give write informed consent Have high school level education Have selfreported interest psychedelic drug alter state consciousness Have use classic , serotonergic hallucinogen dissociative anesthetic hallucinogen ( e.g. , LSD , psilocybin mushroom , ayahuasca , ketamine , PCP ) without untoward effect . Volunteers must report `` like '' psychedelic psychedeliclike drug report use hallucinogen least 5 time lifetime least within last 2 year Agree consume approximately amount caffeinecontaining beverage ( e.g. , coffee , tea ) he/she consume usual morning , arrive research unit morning drug session day . If volunteer usually consume caffeinated beverage , must agree session day Cigarette smoker must agree abstain smoking session day 1 hour drug administration least 6 hour drug administration Agree refrain use psychoactive drug , include alcoholic beverage , within 24 hour drug administration . Exceptions include daily use caffeine nicotine . Be healthy psychologically stable determine screen medical problem via personal interview , medical questionnaire , physical examination , electrocardiogram ( ECG ) , routine medical blood urinalysis laboratory test Agree one week session , he/she refrain take nonprescription medication , nutritional supplement , herbal supplement except approve study investigator . Exceptions evaluate study investigator include acetaminophen , nonsteroidal antiinflammatory drug , common dos vitamin mineral Agree take PRN prescription medication morning session Be willing able participate Exclusion criterion : Women pregnant ( indicated positive urine pregnancy test assess intake drug session ) nursing ; woman childbearing potential sexually active practice effective mean birth control Cardiovascular condition : coronary artery disease , stroke , angina , uncontrolled hypertension , clinically significant ECG abnormality ( e.g. , atrial fibrillation ) , TIA past year Epilepsy history seizure Insulindependent diabetes ; take oral hypoglycemic agent , history hypoglycemia Currently take psychoactive prescription medication regular ( e.g. , daily ) basis Currently take regular ( e.g. , daily ) basis medication primary centrallyacting pharmacological effect serotonin neuron medication MAO inhibitor . For individual intermittent PRN use medication , session conduct least 5 halflives agent elapse last dose More 20 % outside upper low range ideal body weight Psychiatric Current past history meeting DSMIV criterion schizophrenia , psychotic disorder ( unless substanceinduced due medical condition ) , bipolar I II disorder Current severe obsessivecompulsive disorder , dysthymic disorder , panic disorder . Current , severe , major depression Have first second degree relative schizophrenia , psychotic disorder ( unless substance induce due medical condition ) , bipolar I II disorder Currently meet DSMIV criterion dissociative disorder , anorexia nervosa , bulimia nervosa , psychiatric condition judge incompatible establishment rapport safe exposure study compound</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Hallucinogen</keyword>
	<keyword>Cognitive effect</keyword>
	<keyword>Subjective effect</keyword>
</DOC>